Blueshift Asset Management, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Blueshift Asset Management, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2021$617,0000.0%11,635
+25.6%
0.05%
+58.8%
Q2 2021$617,000
-7.9%
9,264
+20.7%
0.03%
-62.6%
Q3 2020$670,000
-37.3%
7,675
-17.5%
0.09%
-25.4%
Q4 2019$1,069,000
+336.3%
9,305
+232.7%
0.12%
+258.8%
Q1 2019$245,0002,7970.03%
Other shareholders
HAEMONETICS CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders